Table 3. Comparison of the incidence and... | American Society of Hematology

Table 3.

Comparison of the incidence and outcome of the retinoic acid syndrome

Study, y	N	Induction	Incidence (%)	Mortality (%) of patients with RAS	Mortality (%) of all treated patients due to RAS
Fenaux et al,²⁸1999	413	ATRA ± Chemo	15	8	1
Frankel et al,⁴¹ 1994	78	ATRA	27	29	8
Tallman et al,²⁹ 1997	172	ATRA	26	5	1
Asou et al,³²1998	196	ATRA ± Chemo	6	9	0.5
Firkin et al,⁴⁴1999	87	ATRA + Steroids	16	21	3
Avvisati,⁴²1998	480	ATRA + Chemo	9	4	0.4
Sanz et al,¹⁴1999	123	ATRA + Chemo	6	17	0.8

Study, y	N	Induction	Incidence (%)	Mortality (%) of patients with RAS	Mortality (%) of all treated patients due to RAS
Fenaux et al,²⁸1999	413	ATRA ± Chemo	15	8	1
Frankel et al,⁴¹ 1994	78	ATRA	27	29	8
Tallman et al,²⁹ 1997	172	ATRA	26	5	1
Asou et al,³²1998	196	ATRA ± Chemo	6	9	0.5
Firkin et al,⁴⁴1999	87	ATRA + Steroids	16	21	3
Avvisati,⁴²1998	480	ATRA + Chemo	9	4	0.4
Sanz et al,¹⁴1999	123	ATRA + Chemo	6	17	0.8